Insights

Expansion Partnerships Capitalize on expansion via majority stake in Green Cross Genetics Lab to broaden diagnostic reach across India and neighboring markets, leveraging CAP accredited labs to win enterprise hospital partnerships.

Broad Test Portfolio Extensive test portfolio with over 1300 genetic assays spanning rare inherited disorders, oncology, reproductive health, infectious diseases and wellness provides multiple cross sell opportunities to hospitals, diagnostics chains and clinics.

AI Enabled Diagnostics Wields in-house sequencing, proprietary assays and AI enabled bioinformatics to deliver actionable genomic insights, enabling hospitals and clinics to strengthen diagnostic decision support and faster reporting.

New Platform Launches Launches of an RNA sequencing platform for Sarcoma diagnosis, the MetaSeq blood test, and a CNS Tumor Methylation Classifier position MedGenome to win partnerships with cancer centers, neurology clinics and academic hospitals.

Global Footprint Global footprint with hundreds of locations in India and multiple countries, supported by digital awareness campaigns and steady funding, signals readiness to pursue large multi-market enterprise deals and scalable BD opportunities.

MEDGENOME Tech Stack

MEDGENOME uses 8 technology products and services including LinkedIn Ads, Facebook Pixel, RSS, and more. Explore MEDGENOME's tech stack below.

  • LinkedIn Ads
    Advertising
  • Facebook Pixel
    Analytics
  • RSS
    Content Management System
  • Swiper
    Javascript Libraries
  • Ahrefs
    Search Marketing
  • X-XSS-Protection
    Security
  • GoDaddy
    Web Hosting
  • Conditional Fields for Contact Form 7
    Widgets

MEDGENOME's Email Address Formats

MEDGENOME uses at least 1 format(s):
MEDGENOME Email FormatsExamplePercentage
First.L@medgenome.comJohn.D@medgenome.com
59%
First.Last@medgenome.comJohn.Doe@medgenome.com
27%
FLast@medgenome.comJDoe@medgenome.com
7%
FirstL@medgenome.comJohnD@medgenome.com
7%

Frequently Asked Questions

Where is MEDGENOME's headquarters located?

Minus sign iconPlus sign icon
MEDGENOME's main headquarters is located at Electronics City, Karnataka 560100 India. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is MEDGENOME's phone number?

Minus sign iconPlus sign icon
You can contact MEDGENOME's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MEDGENOME's official website and social media links?

Minus sign iconPlus sign icon
MEDGENOME's official website is medgenome.com and has social profiles on LinkedInCrunchbase.

What is MEDGENOME's SIC code NAICS code?

Minus sign iconPlus sign icon
MEDGENOME's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MEDGENOME have currently?

Minus sign iconPlus sign icon
As of June 2026, MEDGENOME has approximately 1K employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer (india): V. R.Cfo's Office: S. D.Cfo: S. C.. Explore MEDGENOME's employee directory with LeadIQ.

What industry does MEDGENOME belong to?

Minus sign iconPlus sign icon
MEDGENOME operates in the Biotechnology Research industry.

What technology does MEDGENOME use?

Minus sign iconPlus sign icon
MEDGENOME's tech stack includes LinkedIn AdsFacebook PixelRSSSwiperAhrefsX-XSS-ProtectionGoDaddyConditional Fields for Contact Form 7.

What is MEDGENOME's email format?

Minus sign iconPlus sign icon
MEDGENOME's email format typically follows the pattern of First.L@medgenome.com. Find more MEDGENOME email formats with LeadIQ.

How much funding has MEDGENOME raised to date?

Minus sign iconPlus sign icon
As of June 2026, MEDGENOME has raised $48M in funding. The last funding round occurred on Jul 21, 2025 for $48M.

When was MEDGENOME founded?

Minus sign iconPlus sign icon
MEDGENOME was founded in 2013.

MEDGENOME

Biotechnology ResearchKarnataka, India1001-5000 Employees

MedGenome is a biotechnology research company focused on genomics and precision diagnostics, based in Electronics City, Karnataka, India. It operates South Asia’s largest CAP-accredited genetic testing laboratory and offers a diverse menu of more than 1,300 genetic assays across key disease areas. By integrating sequencing with in-house assays and AI-enabled bioinformatics, the company translates genomic data into insights that support clinical decision-making in complex cases.

Its diagnostic capabilities span rare inherited disorders, oncology, reproductive health, infectious diseases and preventive wellness. MedGenome serves clinicians and healthcare institutions across India and multiple countries, supported by a robust research foundation and extensive collaborations. In 2026, it introduced an RNA sequencing platform for sarcoma diagnosis, reflecting ongoing expansion of its genomic diagnostics capabilities.

Section iconCompany Overview

Headquarters
Electronics City, Karnataka 560100 India
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
1001-5000

Section iconFunding & Financials

  • $48M

    MEDGENOME has raised a total of $48M of funding over 9 rounds. Their latest funding round was raised on Jul 21, 2025 in the amount of $48M.

  • $25M$50M

    MEDGENOME's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $48M

    MEDGENOME has raised a total of $48M of funding over 9 rounds. Their latest funding round was raised on Jul 21, 2025 in the amount of $48M.

  • $25M$50M

    MEDGENOME's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.